Correlation between the single, high dose of ingested baclofen and clinical symptoms
More details
Hide details
Department of Clinical Toxicology, Medical University of Gdansk, Poland
Pomeranian Center of Toxicology, Poland
Department of Medicine, Higher Vocational State School in Kalisz, Poland
Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Warsaw, Poland
Corresponding author
Jacek Sein Anand   

Department of Clinical Toxicology, Medical University of Gdansk, Poland
Ann Agric Environ Med. 2017;24(4):566-569
Introduction and Objectives:
Baclofen is a drug used mainly to treat muscle spasticity. Its overdose can lead to life-threatening clinical symptoms, including acute respiratory failure requiring mechanical ventilation. The aim of this study was to assess the prevalence of selected clinical symptoms associated with baclofen poisoning comparing to an ingested dose.

Material and Methods:
60 cases of oral baclofen poisoning were analyzed. Gender, age distribution, and correlation between the dose of ingested baclofen were studied, as well as and following clinical parameters: degree of altered consciousness, heart rate, blood pressure, presence of acute respiratory failure, duration of mechanical ventilation, and presence of psychotic symptoms.

The study found statistically significant correlations between dosage of ingested baclofen and presence of acute respiratory failure, as well as duration of mechanical ventilation. No statistically significant correlations were found between the dose of ingested baclofen and presence of hypertension, bradycardia, acute psychotic symptoms, or level of consciousness disturbance. However, it was found that patients who suffered from hypertension, bradycardia, and altered mental status ingested a larger dose of baclofen.

There is a statistically significant correlation between the dose of ingested baclofen and the presence of acute respiratory failure, and duration of mechanical ventilation. Patients who have taken a single dose of baclofen of 200 mg, or higher, should be managed in centres able to provide continuous monitoring of life functions. Those with a higher level of a single dose of baclofen ingestion (>500 mg), should be hospitalized in a Toxicology Unit or Intensive Care Unit able to provide airway support and mechanical ventilation.

Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf. 2004; 27(11): 799–818.
Anderson P, Noher H, Swahn CG. Pharmacokinetics in baclofen overdose. J Toxicol Clin Toxicol. 1984; 22(1): 11–20.
Ghose K, Holmes KM, Matthewson K. Complications of baclofen overdosage. Postgrad Med J. 1980; 56(662): 865–867.
Wu VC, Lin SL, Lin SM, Fang CC. Treatment of baclofen overdose by haemodialysis: a pharmacokinetic study. Nephrol Dial Transplant. 2005; 20(2): 441–43.
Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, et al. Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam. Am J Med. 2006; 119(3): 276.e13–276.e18.
Howland RH. Baclofen for the treatment of alcohol dependence. J Psychosoc Nurs Ment Health Serv. 2012; 50(10): 11–14.
Perry HE, Wright RO, Shannon MW, Woolf AD. Baclofen overdose: Drug experimentation in a group of adolescents. Pediatrics. 1998; 101(6): 1045–1048.
Weisshaar GF, Hoemberg M, Bender K, Bangen U, Herkenrath P, Eifinger F, et al. Baclofen intoxication: a “fun drug” causing deep coma and nonconvulsive status epilepticus – a case report and review of the literature. Eur J Pediatr. 2012; 171(10): 1541–1547.
Paeslack V. Lioresal in the treatment of spinal spasticity. Postgrad Med J. 1972; 48(Suppl 5): 30–34.
Haubenstock A, Hruby K, Jäger U, Lenz K. Baclofen (Lioresal) intoxication – report of 4 cases and review of the literature. J Toxicol Clin Toxicol. 1983; 20(1): 59–68.
Leung NY, Whyte IM, Isbister GK. Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas. 2006; 18(1): 77–82.
Franchitto N, Pelissier F, Lauque D, Simon N, Lançon C. Self-Intoxication with Baclofen in Alcohol-Dependent Patients with Co-existing Psychiatric Illness: An Emergency Department Case Series. Alcohol Alcohol. 2014; 49(1): 79–83.
Pommier Ph, Debaty G, Bartoli M, Viglino D, Carpentier F, Danel V et al. Severity of Deliberate Acute Baclofen Poisoning: A Nonconcurrent Cohort Study. Basic Clin Pharmacol Toxicol. 18, Oct. 2013; doi: 10.1111/bcpt.12161.
Fraser AD, MacNeil W, Isner AF. Toxicological analysis of a fatal baclofen (Lioresal) ingestion. J Forensic Sci. 1991; 36(5): 1596–1602.
Lipscomb DJ, Meredith TJ. Baclofen overdose. Postgrad Med J. 1980; 56(652): 108–109.
Sullivan R, Hodgman MJ, Kao L, Tormoehlen LM. Baclofen overdose mimicking brain death. Clin Toxicol. 2012; 50(2): 141–144.
Pizon AF, LoVecchio F. Reversible Cardiomyopathy Complicating Intrathecal Baclofen Withdrawal: A Case Report. J Med Toxicol. 2007; 41: 187–189.
Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012; 50: 107–111.
Byrnes SMA, Watson GW, Hardy PAJ. Flumazenil: An unreliable antagonist in baclofen overdose. Anaesthesia. 1996; 51(5): 481–482.
Saltuari L, Baumgartner H, Kofler M, Schmutzhard E, Russegger L, Aichner F, et al. Failure of physostigmine in treatment of acute severe intrathecal baclofen intoxication. N Engl J Med. 1990; 322(21): 1533–1534.
Ferner RE. Atropine treatment for baclofen overdose. Postgrad Med J. 1981; 57(671): 580–581.
Bassilios N, Launay-Vacher V, Mercadal L, Deray G. Baclofen unerotoxicity in a chronic haemodialysis patient. Nephrol Dial Transplant. 2000; 15(5): 715–716.
Brvar M, Vrtovec M, Kovac D, Kozelj G, Pezdir T, Bunc M. Haemodialysis clearance of baclofen. Eur J Clin Pharmacol. 2007; 63(12): 1143–1146.
Hsieh MJ, Chen SC, Weng TI, Fang CC, Tsai TJ. Treating baclofen overdose by hemodialysis. Am J Emerg Med. 2012; 30(8): 1654.e5–1654.e7.
Dias LS, Vivek G, Manthappa M, Acharya RV. Role of hemodialysis in baclofen overdose with normal renal function. Indian J Pharmacol 2011; 43(6): 722–723.
Journals System - logo
Scroll to top